The U.S. Food and Drug Administration (FDA) recently granted full approval to Balversa (erdafitinib) for the treatment of adult patients with locally ···【Read More】
Update: 2026-04-07Source: Haiou HealthViews: 125
On August 29, Genzo Pharmaceuticals announced that it has filed a supplemental New Drug Application (NDA) with the US Food and Drug Administration (FD···【Read More】
Update: 2026-04-07Source: Haiou HealthViews: 106
When you begin or stop taking Epclusa, your doctor may need to adjust the dosages of any other medications you take regularly.Certain drugs should not···【Read More】
Update: 2026-04-07Source: Haiou HealthViews: 110
This medication will not stop your infection from spreading to others. Avoid unprotected sexual intercourse and do not share razors or toothbrushes. C···【Read More】
Update: 2026-04-07Source: Haiou HealthViews: 114
Seek immediate emergency medical care or call the Poison Control Helpline.【Read More】
Update: 2026-04-07Source: Haiou HealthViews: 119
Take your dose as soon as you realize you’ve forgotten it, then resume your normal dosing schedule. Do not take a double dose to make up for the misse···【Read More】
Update: 2026-04-07Source: Haiou HealthViews: 127
Epclusa contains the active ingredients sofosbuvir and velpatasvir as a fixed-dose combination product, indicated for the treatment of chronic hepatit···【Read More】
Update: 2026-04-07Source: Haiou HealthViews: 109
Side Effects of EpclusaUnderstanding the potential side effects of Epclusa helps patients prepare mentally, identify abnormal symptoms in a timely man···【Read More】
Update: 2026-04-07Source: Haiou HealthViews: 118
Patients should strictly adhere to the recommended dosage of Epclusa under the guidance of their physician, avoiding missed doses or arbitrary changes···【Read More】
Update: 2026-04-03Source: Haiou HealthViews: 110
Epclusa is an important antiviral drug for hepatitis C developed by Gilead Sciences, Inc., providing comprehensive treatment options for patients with···【Read More】
Update: 2026-04-03Source: Haiou HealthViews: 110
Epclusa is a fixed-dose combination therapy consisting of sofosbuvir and velpatasvir, approved by the US FDA for the treatment of chronic hepatitis C ···【Read More】
Update: 2026-04-03Source: Haiou HealthViews: 110
Epclusa is a radical treatment for pangenotypic chronic hepatitis C, and its efficacy has been widely validated in clinical practice. As a potent anti···【Read More】
Update: 2026-04-03Source: Haiou HealthViews: 118
The price of Epclusa (sofosbuvir/velpatasvir tablets) varies depending on the region, purchase channel, and medical insurance policy. In China, the pr···【Read More】
Update: 2026-04-03Source: Haiou HealthViews: 117
The price of Epclusa (sofosbuvir/velpatasvir tablets) in China may fluctuate slightly depending on regional, hospital, or pharmacy policies. This is a···【Read More】
Update: 2026-04-03Source: Haiou HealthViews: 138
The price of Epclusa (sofosbuvir/velpatasvir tablets) is affected by factors such as region, purchase channel, and medical insurance policy. The speci···【Read More】
Update: 2026-04-03Source: Haiou HealthViews: 139
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



